Outlook Therapeutics Inc. buy BiotechBee
Start price
12.06.24
/
50%
€7.30
Target price
28.02.26
€10.00
Performance (%)
-80.96%
End price
14.12.24
€1.39
Summary
This prediction ended on 14.12.24 with a price of €1.39. Massive losses of -80.96% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Outlook Therapeutics Inc. | 54.370% | 54.370% | -34.051% |
| iShares Core DAX® | 0.271% | 1.796% | 4.850% |
| iShares Nasdaq 100 | 1.884% | 2.153% | 37.074% |
| iShares Nikkei 225® | 3.579% | 5.306% | 58.395% |
| iShares S&P 500 | 0.151% | 1.090% | 25.282% |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0